Loading candles…
Fabtech Technologies Ltd, incorporated in 2018, is a biopharma engineering company that provides turnkey design, engineering, and manufacturing solutions for cleanrooms, sterile processing, and containment. Its services include design, engineering, and manufacturing tailored for critical environments. The company primarily serves the pharmaceutical, biotech, and healthcare industries across more than 60 countries worldwide. Fabtech Technologies supports global pharmaceutical companies in establishing and scaling manufacturing facilities. It operates globally but does not have any publicly listed shares or known subsidiaries.
This page is a live market overview for FABTECH TECHNOLOGIES LTD (FABTECH) on the NSE. As a listed security, FABTECH TECHNOLOGIES LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for FABTECH before placing trades on tick2trade.
As of the latest feed, FABTECH last traded at ₹148.63 on NSE, down ₹1.62 (1.08%) from the previous close of ₹150.25. Today's session range is ₹148 – ₹153, against a 52-week band of ₹132.7 – ₹262.8. Traded volume today stands at 52.58K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for FABTECH in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether FABTECH is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for FABTECH TECHNOLOGIES LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in FABTECH. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated FABTECH option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 24 Jul 2026 |
| Dividend | To consider dividend for the Financial Year ended March 31, 2026. | 27 Apr 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 | 27 Apr 2026 |
| Results - Q3-FY25 | To consider and approve the financial results for the Quarter ended December 31, 2025 | 2 Feb 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.